Financials

  • Market Capitalization 396.11 M
  • Employee 120
  • Founded 1995
  • CEO N/A
  • Website www.enanta.com
  • Headquarter Massachusetts, United States
  • FIGI BBG001V9NSB4
  • Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
-6.02
Rapporto prezzo/fatturato

Related tickers

#NomePrezzo24h %7d %1M %1Y %Valore di MercatoUltimi 7 Giorni
3076
XFOR
X4 Pharmaceuticals, Inc. - Common Stock
4.04 USD-4.49%+0.25%+1.00%+36.03%400.55 M USD
3079
LXEO
Lexeo Therapeutics, Inc. - Common Stock
4.86 USD-2.61%-0.41%+10.96%+1.89%398.74 M USD
3090
CTNM
Contineum Therapeutics, Inc. - Common stock
17.05 USD-1.16%+0.29%+8.25%+11.66%393.84 M USD
3107
EYPT
EyePoint, Inc. - Common Stock
4.48 USD-3.24%-13.35%-65.03%-62.67%386.23 M USD

Notizie